Natural Alternatives International, Inc. (NAII)
- Previous Close
6.68 - Open
6.68 - Bid 6.50 x 100
- Ask --
- Day's Range
6.50 - 6.68 - 52 Week Range
5.06 - 9.40 - Volume
2,487 - Avg. Volume
5,414 - Market Cap (intraday)
39.577M - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
-- - EPS (TTM)
-0.70 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.
www.nai-online.comRecent News: NAII
Performance Overview: NAII
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NAII
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NAII
Valuation Measures
Market Cap
39.58M
Enterprise Value
80.28M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.30
Price/Book (mrq)
0.46
Enterprise Value/Revenue
0.63
Enterprise Value/EBITDA
295.14
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.22%
Return on Assets (ttm)
-1.42%
Return on Equity (ttm)
-4.70%
Revenue (ttm)
127.76M
Net Income Avi to Common (ttm)
-4.11M
Diluted EPS (ttm)
-0.70
Balance Sheet and Cash Flow
Total Cash (mrq)
32.13M
Total Debt/Equity (mrq)
20.58%
Levered Free Cash Flow (ttm)
5.84M